Cargando…
Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
The association between inflammatory bowel disease and colorectal cancer is well known. Although the overall incidence of inflammatory bowel disease has declined recently, patients with this disease still have a 1.7-fold increased risk of colorectal cancer. The risk factors for developing colorectal...
Autores principales: | Hsiao, Shun-Wen, Yen, Hsu-Heng, Chen, Yang-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668496/ https://www.ncbi.nlm.nih.gov/pubmed/35670121 http://dx.doi.org/10.5009/gnl210479 |
Ejemplares similares
-
Metabolic Dysfunction-Associated Fatty Liver Disease in Taiwanese Patients with Inflammatory Bowel Disease: A Study in Patients with Clinical Remission
por: Hsiao, Shun-Wen, et al.
Publicado: (2023) -
Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis
por: Qiu, Xinyun, et al.
Publicado: (2016) -
Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease
por: Chen, Tong, et al.
Publicado: (2019) -
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
por: Wei, Shu-Chen, et al.
Publicado: (2017) -
Therapeutic effects of lentinan on inflammatory bowel disease and colitis‐associated cancer
por: Liu, Yanrong, et al.
Publicado: (2018)